ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,735,113 | +7.8% | 84,681 | +4.6% | 0.02% | +11.1% |
Q2 2023 | $1,609,114 | +8.7% | 80,982 | -6.3% | 0.02% | +5.9% |
Q1 2023 | $1,479,929 | -41.3% | 86,394 | -33.0% | 0.02% | -41.4% |
Q4 2022 | $2,522,850 | +80.5% | 128,914 | +47.7% | 0.03% | +70.6% |
Q3 2022 | $1,398,000 | +15.7% | 87,253 | -0.5% | 0.02% | +21.4% |
Q2 2022 | $1,208,000 | -7.5% | 87,661 | +6.6% | 0.01% | 0.0% |
Q1 2022 | $1,306,000 | -5.4% | 82,236 | +29.4% | 0.01% | 0.0% |
Q4 2021 | $1,381,000 | -5.5% | 63,573 | +29.8% | 0.01% | -6.7% |
Q3 2021 | $1,461,000 | -21.7% | 48,962 | +16.2% | 0.02% | -16.7% |
Q2 2021 | $1,867,000 | +33.5% | 42,138 | +33.8% | 0.02% | +12.5% |
Q1 2021 | $1,398,000 | -47.0% | 31,500 | -34.5% | 0.02% | -46.7% |
Q4 2020 | $2,639,000 | +104.7% | 48,072 | -14.7% | 0.03% | +76.5% |
Q3 2020 | $1,289,000 | +19.5% | 56,385 | +9.4% | 0.02% | +6.2% |
Q2 2020 | $1,079,000 | +0.3% | 51,544 | -33.2% | 0.02% | +6.7% |
Q1 2020 | $1,076,000 | +45.4% | 77,178 | +137.5% | 0.02% | +50.0% |
Q4 2019 | $740,000 | – | 32,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |